Molecular evolution of human immunodeficiency virus env in humans and monkeys:: Similar patterns occur during natural disease progression or rapid virus passage

被引:19
作者
Hofmann-Lehmann, R
Vlasak, J
Chenine, AL
Li, PL
Baba, TW
Montefiori, DC
McClure, HM
Anderson, DC
Ruprecht, RM
机构
[1] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Tufts Univ, Sch Med, Div Newborn Med, Boston, MA 02111 USA
[4] Duke Univ, Med Ctr, Dept Surg, Ctr AIDS Res, Durham, NC 27710 USA
[5] Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30322 USA
关键词
D O I
10.1128/JVI.76.10.5278-5284.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Neonatal rhesus macaque 95-3 was inoculated with nonpassaged simian-human immunodeficiency virus strain SHIV-vpu(+), which encodes env of the laboratory-adapted human immunodeficiency virus (HIV) strain IIIB and is considered nonpathogenic. CD4(+) T-cell counts dropped to <200 cells/mul within 4.6 years, and monkey 95-3 died with opportunistic infections 5.9 years postinoculation. Transfer of blood from 95-3 to two naive adult macaques resulted in high peak viral loads and rapid, persistent T-cell depletion. Progeny virus evolved in 95-3 despite high SHIV-vpu(+) neutralizing antibody titers and still used CXCR4 but, in contrast to parental SHIV-vpu(+), productively infected macrophages and resisted neutralization. Sequence analysis revealed three new potential glycosylation sites in gp120; another two were lost. Strikingly similar mutations were detected in a laboratory worker who progressed to AIDS after accidental HIV-IIIB infection (T. Beaumont et al., J. Virol. 75:2246-2252, 2001), thus supporting the SHIV-v-pu(+)/rhesus macaque system as a relevant model. Similar mutations were also described after rapid passage of chimeric viruses encoding IIIB env in rhesus and pig-tailed macaques (M. Cayabyab et al., J. Virol. 73:976-984, 1999; Z. Q. Liu et al., Virology 260:295-307, 1999; S. V. Narayan et al., Virology 256:54-63, 1999; R. Raghavan et al., Brain Pathol. 7:851-861, 1997; E. B. Stephens et al., Virology 231:313-321, 1997). Thus, HIV-IIIB env evolved similarly in three different species; this selection occurred in chronically infected individuals during disease progression as well as after rapid virus passage. We postulate that evolutionary pressure led to the outgrowth of more aggressive viral variants in all three species.
引用
收藏
页码:5278 / 5284
页数:7
相关论文
共 50 条
[1]   MUCOSAL INFECTION OF NEONATAL RHESUS-MONKEYS WITH CELL-FREE SIV [J].
BABA, TW ;
KOCH, J ;
MITTLER, ES ;
GREENE, M ;
WYAND, M ;
PENNINCK, D ;
RUPRECHT, RM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :351-357
[2]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[3]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[4]   Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course [J].
Beaumont, T ;
van Nuenen, A ;
Broersen, S ;
Blattner, WA ;
Lukashov, VV ;
Schuitemaker, H .
JOURNAL OF VIROLOGY, 2001, 75 (05) :2246-2252
[5]   Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1 [J].
Binley, JM ;
Klasse, PJ ;
Cao, YZ ;
Jones, I ;
Markowitz, M ;
Ho, DD ;
Moore, JP .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2799-2809
[6]   Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1 [J].
Bures, R ;
Gaitan, A ;
Zhu, TF ;
Graziosi, C ;
McGrath, KM ;
Tartaglia, J ;
Caudrelier, P ;
EL Habib, R ;
Klein, M ;
Lazzarin, A ;
Stablein, DM ;
Deers, M ;
Corey, L ;
Greenberg, ML ;
Schwartz, DH ;
Montefiori, DC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (18) :2019-2035
[7]   Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein [J].
Cao, J ;
Sullivan, N ;
Desjardin, E ;
Parolin, C ;
Robinson, J ;
Wyatt, R ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9808-9812
[8]   Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2) [J].
Cayabyab, M ;
Karlsson, GB ;
Etemad-Moghadam, BA ;
Hofmann, W ;
Steenbeke, T ;
Halloran, M ;
Fanton, JW ;
Axthelm, MK ;
Letvin, NL ;
Sodroski, JG .
JOURNAL OF VIROLOGY, 1999, 73 (02) :976-984
[9]   Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo [J].
Etemad-Moghadam, B ;
Sun, Y ;
Nicholson, EK ;
Karlsson, GB ;
Schenten, D ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8873-8879
[10]   IDENTIFICATION AND CHARACTERIZATION OF A NEUTRALIZATION SITE WITHIN THE 2ND VARIABLE REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 [J].
FUNG, MSC ;
SUN, CRY ;
GORDON, WL ;
LIOU, RS ;
CHANG, TW ;
SUN, WNC ;
DAAR, ES ;
HO, DD .
JOURNAL OF VIROLOGY, 1992, 66 (02) :848-856